DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$7.69
+0.21 (+2.81%)
Open$7.50
Previous Close$7.48
Day High$7.96
Day Low$7.49
52W High$8.82
52W Low$3.53
Volume—
Avg Volume233.8K
Market Cap187.58M
P/E Ratio—
EPS$-3.67
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+299.1% upside
Current
$7.69
$7.69
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 65.16M | 58.74M | 15.69M |
| Net Income | -86,958,675 | -70,551,525 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -76,089,145 | -65,162,433 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |